Short description
Biotech company focused on protein conjugation.
Description
Catena Biosciences is a biotech startup based on research from the Francis and Doudna labs at UC Berkeley focusing on the treatment and cure of autoimmune disorders. Catena’s platform differentiates on the ability to fuse proteins together using enzyme activation of native amino acids to create new treatments in oncology, autoimmune disorders and vaccine development!
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Berkeley, California, United States, North America
Founded on
November 17, 2020
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$56378 - 90123
Sign in for full access
Investors
Absolutely Noaccess, Noaccess, Cannot Access, Noaccess, Noaccess, Noway Youcantaccess, Noway Youcantaccess, Noaccess, Noway Youcantaccess, No Way, Noway Youcantaccess, Noway Youcantaccess
Sign in for full access
Founders
Gregorio Guillen, Marco Lobba, Matthew Francis